C.M. Bidwell & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,095
Closed -$248K 549
2026
Q1
$248K Buy
+2,095
New +$259K 0.12% 115
2024
Q4
Sell
-14
Closed -$2.73K 541
2024
Q3
$2.73K Buy
+14
New +$2.58K ﹤0.01% 421
2021
Q1
Sell
-606
Closed -$100K 558
2020
Q4
$100K Sell
606
-42
-6% -$6.83K 0.08% 238
2020
Q3
$107K Buy
+648
New +$99.6K 0.1% 196
2020
Q1
Sell
-1,705
Closed -$226K 480
2019
Q4
$226K Sell
1,705
-1,535
-47% -$191K 0.2% 104
2019
Q3
$404K Sell
3,240
-215
-6% -$26K 0.4% 66
2019
Q2
$392K Buy
+3,455
New +$362K 0.39% 81
2019
Q1
Sell
-1,175
Closed -$101K 482
2018
Q4
$101K Buy
+1,175
New +$106K 0.11% 173
2018
Q2
Sell
-5,200
Closed -$434K 461
2018
Q1
$434K Buy
+5,200
New +$410K 0.4% 67
2017
Q1
Sell
-71,880
Closed -$3.85M 293
2016
Q4
$3.85M Buy
+71,880
New +$3.65M 0.91% 48

Other funds holding ZTS

C.M. Bidwell & Associates's ZTS Position: Q2 2026 in Review

C.M. Bidwell & Associates sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,095 shares — an estimated $248K sold.

C.M. Bidwell & Associates first reported a position in ZTS in Q4 2016 and held it in 10 quarters. The position peaked at $3.85M in Q4 2016. 1,430 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • C.M. Bidwell & Associates reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 2,095 Zoetis shares in Q2 2026, an estimated $248K.
  • C.M. Bidwell & Associates first reported a position in Zoetis in Q4 2016 and held it in 10 quarters.
  • C.M. Bidwell & Associates's Zoetis position peaked at $3.85M in Q4 2016.
  • 1,430 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.